Immune cell neural interactions and their contributions to sickle cell disease

被引:8
|
作者
Sagi, Varun [1 ]
Mittal, Aditya [1 ]
Gupta, Mihir [2 ]
Gupta, Kalpna [1 ]
机构
[1] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Vasc Biol Ctr, Box 736 UMHC, Minneapolis, MN 55455 USA
[2] Univ Calif San Diego, Dept Neurosurg, La Jolla, CA 92093 USA
关键词
Sickle cell disease; Pain; Mast cells; Serpins; Inflammation; MAST-CELLS; CYCLOOXYGENASE-2; EXPRESSION; SUBSTANCE-P; PAIN; ACTIVATION; MECHANISMS; SENSITIZATION; MICE; ADHESION; NEURONS;
D O I
10.1016/j.neulet.2019.02.008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Sickle cell disease (SCD) is characterized by hemolysis, inflammation, and pain. Mechanisms of pain manifestation are complex, and there is a major gap in knowledge of how the nervous and immune systems interact to contribute to pain and other comorbidities in SCD. Sterile inflammation in the periphery and central nervous system contributes to vascular and neural activation. Cellular and soluble mediators create an inflammatory and neuroinflammatory microenvironment contributing to neurogenic inflammation and acute and chronic pain. In this review we highlight relevant neuro-immune interactions that contribute to the pathobiology of SCD.
引用
收藏
页码:167 / 171
页数:5
相关论文
共 50 条
  • [31] Spinal and afferent PKC signaling mechanisms that mediate chronic pain in sickle cell disease
    He, Ying
    Wang, Zaijie Jim
    NEUROSCIENCE LETTERS, 2019, 706 : 56 - 60
  • [32] Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use
    Brandow, Amanda M.
    Wandersee, Nancy J.
    Dasgupta, Mahua
    Hoffmann, Raymond G.
    Hillery, Cheryl A.
    Stucky, Cheryl L.
    Panepinto, Julie A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (02) : 237 - 245
  • [33] Δ9-Tetrahydrocannabinol Alleviates Hyperalgesia in a Humanized Mouse Model of Sickle Cell Disease
    Tagne, Alex Mabou
    Fotio, Yannick
    Gupta, Kalpna
    Piomelli, Daniele
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2024, 391 (02) : 174 - 181
  • [34] Vaso-occlusive crisis in sickle cell disease: a vicious cycle of secondary events
    Jang, Tim
    Poplawska, Maria
    Cimpeanu, Emanuela
    Mo, George
    Dutta, Dibyendu
    Lim, Seah H.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [35] HMGB1 takes a "Toll" in sickle cell disease
    Gupta, Kalpna
    BLOOD, 2014, 124 (26) : 3837 - 3838
  • [36] Cold hypersensitivity increases with age in mice with sickle cell disease
    Zappia, Katherine J.
    Garrison, Sheldon R.
    Hillery, Cheryl A.
    Stucky, Cheryl L.
    PAIN, 2014, 155 (12) : 2476 - 2485
  • [37] New insights into sickle cell disease: mechanisms and investigational therapies
    Kato, Gregory J.
    CURRENT OPINION IN HEMATOLOGY, 2016, 23 (03) : 224 - 232
  • [38] Pathophysiological characterization of the Townes mouse model for sickle cell disease
    Alvarez-Argote, Juliana
    Dlugi, Theresa A.
    Sundararajan, Teresa
    Kleynerman, Annie
    Faber, Mary L.
    McKillop, William M.
    Medin, Jeffrey A.
    TRANSLATIONAL RESEARCH, 2023, 254 : 77 - 91
  • [39] Temporomandibular joint arthritis in sickle cell disease: a case report
    Caracas, Maira da Silva
    Jales, Sumatra P.
    Jales Neto, Levi H.
    da Silva Castro, Joice Carla
    Suganuma, Liliana Mitie
    Hencklain Fonseca, Guilherme Henrique
    Menosi Gualandro, Sandra Fatima
    Tesseroli de Siqueira, Jose Tadeu
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2013, 115 (02): : E31 - E35
  • [40] Current and Future Therapeutics for Treating Patients with Sickle Cell Disease
    Barak, Mariam
    Hu, Christopher
    Matthews, Alicia
    Fortenberry, Yolanda M.
    CELLS, 2024, 13 (10)